242 related articles for article (PubMed ID: 36723696)
1. The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review.
Murage NW; Ahmed NM; Underwood TJ; Walters ZS; Breininger SP
Cancer Metastasis Rev; 2023 Mar; 42(1):335-359. PubMed ID: 36723696
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
[TBL] [Abstract][Full Text] [Related]
3. A case of Pseudomyxoma Peritonei of an unexpected origin.
Csanyi-Bastien M; Blanchard F; Lamy A; Sabourin JC
Diagn Pathol; 2021 Dec; 16(1):119. PubMed ID: 34930348
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.
Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM
Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
[TBL] [Abstract][Full Text] [Related]
6. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.
Shetty S; Thomas P; Ramanan B; Sharma P; Govindarajan V; Loggie B
J Surg Res; 2013 Mar; 180(1):97-103. PubMed ID: 23199549
[TBL] [Abstract][Full Text] [Related]
7. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
[TBL] [Abstract][Full Text] [Related]
8. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
[TBL] [Abstract][Full Text] [Related]
9. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.
Noguchi R; Yano H; Gohda Y; Suda R; Igari T; Ohta Y; Yamashita N; Yamaguchi K; Terakado Y; Ikenoue T; Furukawa Y
Cancer Med; 2015 Dec; 4(12):1809-16. PubMed ID: 26475379
[TBL] [Abstract][Full Text] [Related]
11. Toward the molecular dissection of peritoneal pseudomyxoma.
Pietrantonio F; Perrone F; Mennitto A; Gleeson EM; Milione M; Tamborini E; Busico A; Settanni G; Berenato R; Caporale M; Morano F; Bossi I; Pellegrinelli A; Di Bartolomeo M; de Braud F; Baratti D; Bowne WB; Kusamura S; Deraco M
Ann Oncol; 2016 Nov; 27(11):2097-2103. PubMed ID: 27502722
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei.
Pengelly RJ; Rowaiye B; Pickard K; Moran B; Dayal S; Tapper W; Mirnezami A; Cecil T; Mohamed F; Carr N; Ennis S
J Mol Diagn; 2018 Sep; 20(5):635-642. PubMed ID: 29936255
[TBL] [Abstract][Full Text] [Related]
13. Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.
Lin YL; Zhu JQ; Ma RQ; Meng W; Wang ZY; Li XB; Ma R; Wu HL; Xu HB; Gao Y; Li Y
Mol Cancer Res; 2024 Jan; 22(1):70-81. PubMed ID: 37768171
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma.
Choi YJ; Lee SH; Kim MS; Jung SH; Hur SY; Chung YJ; Lee SH
Pathology; 2016 Jun; 48(4):372-6. PubMed ID: 27114374
[TBL] [Abstract][Full Text] [Related]
15. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH
Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935
[TBL] [Abstract][Full Text] [Related]
16. Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma.
Taguchi A; Rokutan H; Oda K; Tanikawa M; Tanimoto S; Sone K; Mori M; Tsuruga T; Kohsaka S; Tatsuno K; Shinozaki-Ushiku A; Miyagawa K; Mano H; Aburatani H; Ushiku T; Osuga Y
BMC Med Genomics; 2022 Mar; 15(1):51. PubMed ID: 35255903
[TBL] [Abstract][Full Text] [Related]
17. Macroscopic and microscopic characteristics of low grade appendiceal mucinous neoplasms (LAMN) on appendectomy specimens and correlations with pseudomyxoma peritonei development risk.
Hegg KS; Mack LA; Bouchard-Fortier A; Temple WJ; Gui X
Ann Diagn Pathol; 2020 Oct; 48():151606. PubMed ID: 32889392
[TBL] [Abstract][Full Text] [Related]
18. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression of Appendiceal Mucinous Neoplasm to Pseudomyxoma Peritonei.
Sueda S; Young S; Sung M; Hotta M; O'Connor V; Leung AM
Am Surg; 2020 Oct; 86(10):1379-1384. PubMed ID: 33284666
[TBL] [Abstract][Full Text] [Related]
20. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.
Rauwerdink P; Brosens LAA; van Diepen KK; Ghedri ON; Kranenburg O; Boerma D; Witkamp AJ; van Grevenstein HMU
World J Surg Oncol; 2022 May; 20(1):147. PubMed ID: 35538541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
